What is the appropriate management for a patient with an ejection fraction of 58% and severe mitral regurgitation, moderate tricuspid regurgitation and aortic regurgitation, who is failing to thrive, refusing oral intake, and whose furosemide (Lasix) has been discontinued?

Immediate Management: Reinstitute Diuretic Therapy and Pursue Urgent Multivalve Surgical Evaluation

This patient requires immediate reinstitution of diuretic therapy and urgent cardiothoracic surgery consultation for multivalve intervention—the combination of severe MR, moderate TR and AR with failure to thrive and refusal of oral intake represents advanced valvular heart disease with decompensation that will not improve with medical management alone.

Critical Clinical Context

This patient presents with a preserved EF (58%) but severe symptomatic multivalvular disease—a scenario where the ejection fraction is misleading. The failure to thrive and oral refusal indicate advanced heart failure despite the "normal" EF, likely representing:

• Volume overload from severe MR and moderate AR
• Right heart failure from moderate TR
• Systemic congestion manifesting as anorexia and cachexia

Discontinuing lasix in this context was inappropriate. The patient has clear evidence of fluid overload requiring diuretic management.

Immediate Medical Management

Restore Diuretic Therapy

Diuretics must be restarted immediately 1, 2, 1. For patients with severe valvular regurgitation and signs of right-sided heart failure (which this patient clearly has with TR), diuretics are essential to reduce systemic congestion 2.

• Start IV furosemide 20-40 mg as initial dose, given slowly over 1-2 minutes 3
• If inadequate response within 2 hours, increase by 20 mg increments 3
• Monitor daily weights, intake/output, and electrolytes 1
• Watch for hypotension and worsening renal function, but do not withhold diuretics in the setting of obvious volume overload

The failure to thrive and oral refusal may actually improve with diuresis as hepatic congestion and bowel edema resolve, potentially restoring appetite.

Optimize Volume Status Before Definitive Intervention

• Daily serum electrolytes, BUN, and creatinine during IV diuretic use 1
• If diuresis inadequate, intensify regimen with higher loop diuretic doses, add metolazone or spironolactone, or use continuous infusion 1
• Consider IV vasodilators (nitroglycerin starting 5-10 mcg/min) if severely symptomatic with fluid overload and adequate blood pressure 1, 4

Definitive Management: Surgical Intervention

Multivalve Surgery is Indicated

This patient requires surgical correction of multiple valves 5, 2, 6. The guidelines are clear:

1. Severe MR with symptoms: Surgery is indicated in symptomatic patients with severe primary MR and LVEF >30% 6. Even if this is secondary MR, the patient is symptomatic and failing.

2. Moderate TR at time of left-sided valve surgery: Surgery should be considered for moderate TR when undergoing left-sided valve intervention, especially with annular dilation (≥40 mm) 5, 2, 6. Leaving moderate TR uncorrected leads to progression in ~25% of patients and worse long-term outcomes 2.

3. Moderate AR: While isolated moderate AR doesn't mandate surgery, in the context of other severe valve disease requiring surgery, it should be addressed 6.

Surgical Approach

• Mitral valve repair is preferred over replacement when feasible 6, 7
• Tricuspid valve repair (typically annuloplasty) should be performed concurrently—this adds minimal operative risk but prevents future TR progression 2
• Aortic valve intervention depends on AR mechanism and severity on direct surgical inspection

Delaying surgery in this scenario risks:

• Irreversible RV dysfunction from chronic TR 5
• Progressive cachexia and malnutrition
• Worsening renal and hepatic dysfunction from chronic congestion
• Significantly higher mortality if surgery is delayed until more advanced stage 1

Common Pitfalls to Avoid

1. Being falsely reassured by preserved EF: In severe MR, the EF overestimates true ventricular function because the ventricle ejects into the low-pressure left atrium. This patient likely has worse systolic function than the 58% suggests.

2. Withholding diuretics due to "normal" EF or concern about hypotension: Patients with severe valvular regurgitation and congestion require diuretics regardless of EF 2, 1. The congestion itself worsens outcomes.

3. Treating TR as "functional" and expecting it to resolve: Moderate or greater TR at the time of left-sided valve surgery should be addressed surgically—it rarely improves and often worsens postoperatively if left untreated 5, 2.

4. Delaying surgery for "medical optimization": While volume status should be optimized, this patient needs definitive surgical correction. Prolonged medical management in advanced multivalvular disease leads to irreversible organ damage 1.

Immediate Action Plan

1. Restart IV furosemide immediately with close monitoring
2. Urgent cardiothoracic surgery consultation (within 24-48 hours)
3. Nutritional support (consider temporary NG feeding if oral intake remains inadequate)
4. Comprehensive preoperative evaluation including coronary angiography if age/risk factors warrant
5. Optimize other comorbidities (renal function, anemia, etc.) while preparing for surgery

The key message: This is not a patient for conservative management. The combination of severe symptomatic multivalvular disease with failure to thrive requires aggressive diuresis as a bridge to definitive surgical correction of all significant valve lesions 5, 2, 6, 1.